Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Triamcinolone for Refractory Diabetic Macular Edema
NCT00369863Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2002; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00369863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369863.